title: [Bullous haemorrhagic dermatosis at distant sites due to enoxaparin: An uncommon secondary effect in an anticoagulated oncology patient].
authors.affiliation: Servicio de Dermatología, Hospital Clínico Lozano Blesa, Zaragoza, España. Electronic address: lucia14_prie@msn.com.
authors.forename: L
authors.initials: L
authors.lastname: Prieto-Torres
authors.affiliation: Servicio de Dermatología, Hospital Clínico Lozano Blesa, Zaragoza, España.
authors.forename: T
authors.initials: T
authors.lastname: Gracia Cazaña
authors.affiliation: Servicio de Dermatología, Hospital Clínico Lozano Blesa, Zaragoza, España.
authors.forename: I
authors.initials: I
authors.lastname: Pastushenko
authors.affiliation: Servicio de Dermatología, Hospital Clínico Lozano Blesa, Zaragoza, España.
authors.forename: A L
authors.initials: AL
authors.lastname: Morales Moya
authors.affiliation: Servicio de Anatomía Patológica, Hospital Clínico Lozano Blesa, Zaragoza, España.
authors.forename: J
authors.initials: J
authors.lastname: Soria
authors.affiliation: Servicio de Dermatología, Hospital Clínico Lozano Blesa, Zaragoza, España.
authors.forename: M
authors.initials: M
authors.lastname: Ara Martín
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects; D017984:Enoxaparin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000175:diagnosis; D013927:Thrombosis / Q000139:chemically induced / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D000970:Antineoplastic Agents; D017984:Enoxaparin